Current Medicinal Chemistry - Anti-Cancer Agents
Title: Preface [Hot Topic: Anticancer Agents: To Kill in a Good Cause (Guest Editor : Eric Solary)].
Volume: 3 Issue: 4
Author(s): Eric Solary
Affiliation:
Export Options
About this article
Cite this article as:
Solary Eric, Preface [Hot Topic: Anticancer Agents: To Kill in a Good Cause (Guest Editor : Eric Solary)]., Current Medicinal Chemistry - Anti-Cancer Agents 2003; 3 (4) . https://dx.doi.org/10.2174/1568011033482387
DOI https://dx.doi.org/10.2174/1568011033482387 |
Print ISSN 1568-0118 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5968 |
7
Related Articles
-
Role of Metallothionein in Inflammatory Lung Diseases
Current Respiratory Medicine Reviews Editorial (Thematic Issue: The Lung and Winding Road: Twists and Turns on the Way to Personalized NSCLC Therapy)
Current Pharmaceutical Design Exploiting Internal Ribosome Entry Sites in Gene Therapy Vector Design
Current Gene Therapy Identification and Characterization of the Biosynthetic Gene Cluster of Thiolutin, a Tumor Angiogenesis Inhibitor, in Saccharothrix algeriensis NRRL B-24137
Anti-Cancer Agents in Medicinal Chemistry Current Status of Anti-Tuberculosis Therapy: A Patent Analysis
Recent Patents on Anti-Infective Drug Discovery Volatile Disease Biomarkers in Breath: A Critique
Current Pharmaceutical Biotechnology Formulation and Optimization of 5-Fluorouracil Loaded Chitosan Nanoparticles Employing Central Composite Design
Drug Delivery Letters Therapeutically Targeted Anticancer Agents: Inhibitors of Receptor Tyrosine Kinases
Mini-Reviews in Medicinal Chemistry The Potential of Flavonolignans in Prostate Cancer Management
Current Medicinal Chemistry Recent Advances in Drug Design of Epidermal Growth Factor Receptor Inhibitors
Current Medicinal Chemistry Diagnosis of Pathogens Using DNA Microarray
Recent Patents on Biotechnology PD-1/PD-Ls: A New Target for Regulating Immunopathogenesis in Central Nervous System Disorders
Current Drug Delivery Recent Advances and Patents on Nanoscale Systems and Triggerable Drug Delivery in Medical Devices
Recent Patents on Biomedical Engineering (Discontinued) Oligopeptides for Immunotherapy Approaches in Ovarian Cancer Treatment
Current Drug Discovery Technologies Specific Immune Intervention with Monoclonal Antibodies for the Treatment of Multiple Sclerosis
Current Medicinal Chemistry Selenium in the Prevention and Treatment of Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Synthesis, In Vitro Biological Screening and Molecular Docking Studies of Novel Camphor-Based Thiazoles
Medicinal Chemistry Editorial (Thematic Issue: Immunophilins, Protein Chemistry and Cell Biology of a Promising New Class of Drug Targets – Part II)
Current Molecular Pharmacology Hypoxia Signaling and the Metastatic Phenotype
Current Molecular Medicine Silencing the Transcription Factor FOSL1 in Hyperproliferative HaCaT Cells Makes Them Susceptible to IFN-γ
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)